Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.420
+0.030 (2.16%)
At close: Aug 5, 2025, 4:00 PM
1.410
-0.010 (-0.70%)
After-hours: Aug 5, 2025, 7:48 PM EDT
PACB Stock Forecast
Stock Price Forecast
The 9 analysts that cover PACB stock have a consensus rating of "Buy" and an average price target of $2.06, which forecasts a 45.07% increase in the stock price over the next year. The lowest target is $1.25 and the highest is $3.50.
Price Target: $2.06 (+45.07%)
Analyst Consensus: Buy
* Price targets were last updated on Jun 25, 2025.
Analyst Ratings
The average analyst rating for PACB stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 1 | 1 | 1 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 6 | 6 | 4 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $2 → $1.5 | Hold | Maintains | $2 → $1.5 | +5.63% | Jun 25, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $2 → $1.25 | Hold | Maintains | $2 → $1.25 | -11.97% | May 15, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $1.8 | Buy | Reiterates | $1.8 | +26.76% | May 15, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +111.27% | Apr 10, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $6 → $2 | Buy | Maintains | $6 → $2 | +40.85% | Mar 25, 2025 |
Financial Forecast
Revenue This Year
159.19M
from 154.01M
Increased by 3.36%
Revenue Next Year
188.16M
from 159.19M
Increased by 18.20%
EPS This Year
-1.49
from -1.13
EPS Next Year
-0.55
from -1.49
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 168.2M | 210.8M | 268.7M | ||
| Avg | 159.2M | 188.2M | 231.0M | ||
| Low | 148.0M | 161.2M | 176.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.2% | 32.4% | 42.8% | ||
| Avg | 3.4% | 18.2% | 22.8% | ||
| Low | -3.9% | 1.3% | -6.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.68 | -0.40 | -0.24 | ||
| Avg | -1.49 | -0.55 | -0.41 | ||
| Low | -1.96 | -0.70 | -0.56 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.